Amedisys Operating Margin 2010-2024 | AMED

Current and historical operating margin for Amedisys (AMED) over the last 10 years. The current operating profit margin for Amedisys as of March 31, 2024 is 6.30%.
Amedisys Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-03-31 $2.25B $0.15B 6.49%
2023-12-31 $2.24B $0.16B 6.98%
2023-09-30 $2.23B $0.17B 7.54%
2023-06-30 $2.23B $0.17B 7.40%
2023-03-31 $2.23B $0.18B 7.83%
2022-12-31 $2.22B $0.18B 8.14%
2022-09-30 $2.22B $0.18B 8.24%
2022-06-30 $2.22B $0.20B 9.07%
2022-03-31 $2.23B $0.23B 10.38%
2021-12-31 $2.23B $0.25B 11.32%
2021-09-30 $2.23B $0.27B 11.96%
2021-06-30 $2.22B $0.27B 12.25%
2021-03-31 $2.16B $0.24B 11.30%
2020-12-31 $2.11B $0.22B 10.40%
2020-09-30 $2.05B $0.20B 9.71%
2020-06-30 $2.00B $0.18B 9.17%
2020-03-31 $1.98B $0.18B 8.99%
2019-12-31 $1.96B $0.18B 9.10%
2019-09-30 $1.89B $0.17B 9.11%
2019-06-30 $1.81B $0.17B 9.11%
2019-03-31 $1.73B $0.16B 9.42%
2018-12-31 $1.66B $0.16B 9.33%
2018-09-30 $1.63B $0.15B 9.16%
2018-06-30 $1.58B $0.13B 8.34%
2018-03-31 $1.55B $0.09B 5.76%
2017-12-31 $1.51B $0.08B 5.16%
2017-09-30 $1.46B $0.06B 4.24%
2017-06-30 $1.45B $0.05B 3.66%
2017-03-31 $1.44B $0.07B 4.94%
2016-12-31 $1.42B $0.06B 4.01%
2016-09-30 $1.41B $0.06B 4.26%
2016-06-30 $1.37B $0.06B 4.59%
2016-03-31 $1.33B $0.06B 4.60%
2015-12-31 $1.28B $-0.01B -0.63%
2015-09-30 $1.24B $-0.01B -0.80%
2015-06-30 $1.22B $-0.01B -0.90%
2015-03-31 $1.21B $-0.01B -1.16%
2014-12-31 $1.21B $0.02B 1.99%
2014-09-30 $1.21B $-0.00B -0.08%
2014-06-30 $1.21B $-0.17B -14.16%
2014-03-31 $1.22B $-0.18B -14.77%
2013-12-31 $1.25B $-0.16B -12.41%
2013-09-30 $1.29B $-0.30B -23.04%
2013-06-30 $1.35B $-0.13B -9.47%
2013-03-31 $1.40B $-0.12B -8.36%
2012-12-31 $1.44B $-0.11B -7.63%
2012-09-30 $1.42B $0.06B 4.09%
2012-06-30 $1.42B $-0.51B -35.96%
2012-03-31 $1.43B $-0.49B -34.08%
2011-12-31 $1.42B $-0.47B -33.10%
2011-09-30 $1.46B $-0.43B -29.42%
2011-06-30 $1.49B $0.16B 10.92%
2011-03-31 $1.55B $0.18B 11.57%
2010-12-31 $1.60B $0.21B 13.18%
2010-09-30 $1.62B $0.23B 13.99%
2010-06-30 $1.60B $0.25B 15.63%
2010-03-31 $1.56B $0.25B 16.33%
2009-12-31 $1.48B $0.24B 16.11%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.162B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.759B 16.29
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Chemed (CHE) United States $8.450B 26.19
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00